Eastman Chemical (EMN) Competitors $61.18 +0.27 (+0.43%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$61.63 +0.45 (+0.73%) As of 07:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EMN vs. AVNT, CE, DD, DOW, FUL, HUN, LYB, WLK, PPG, and FMCShould you be buying Eastman Chemical stock or one of its competitors? The main competitors of Eastman Chemical include Avient (AVNT), Celanese (CE), DuPont de Nemours (DD), DOW (DOW), H. B. Fuller (FUL), Huntsman (HUN), LyondellBasell Industries (LYB), Westlake (WLK), PPG Industries (PPG), and FMC (FMC). Eastman Chemical vs. Its Competitors Avient Celanese DuPont de Nemours DOW H. B. Fuller Huntsman LyondellBasell Industries Westlake PPG Industries FMC Avient (NYSE:AVNT) and Eastman Chemical (NYSE:EMN) are both mid-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability. Do analysts prefer AVNT or EMN? Avient currently has a consensus target price of $45.60, suggesting a potential upside of 37.73%. Eastman Chemical has a consensus target price of $87.00, suggesting a potential upside of 42.19%. Given Eastman Chemical's higher probable upside, analysts plainly believe Eastman Chemical is more favorable than Avient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avient 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.71Eastman Chemical 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62 Is AVNT or EMN a better dividend stock? Avient pays an annual dividend of $1.08 per share and has a dividend yield of 3.3%. Eastman Chemical pays an annual dividend of $3.32 per share and has a dividend yield of 5.4%. Avient pays out 84.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Eastman Chemical pays out 46.6% of its earnings in the form of a dividend. Avient has raised its dividend for 1 consecutive years and Eastman Chemical has raised its dividend for 15 consecutive years. Eastman Chemical is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Do insiders & institutionals have more ownership in AVNT or EMN? 95.5% of Avient shares are owned by institutional investors. Comparatively, 83.7% of Eastman Chemical shares are owned by institutional investors. 0.9% of Avient shares are owned by insiders. Comparatively, 1.9% of Eastman Chemical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is AVNT or EMN more profitable? Eastman Chemical has a net margin of 8.96% compared to Avient's net margin of 3.65%. Eastman Chemical's return on equity of 15.24% beat Avient's return on equity.Company Net Margins Return on Equity Return on Assets Avient3.65% 10.57% 4.17% Eastman Chemical 8.96%15.24%5.91% Does the media prefer AVNT or EMN? In the previous week, Eastman Chemical had 18 more articles in the media than Avient. MarketBeat recorded 47 mentions for Eastman Chemical and 29 mentions for Avient. Eastman Chemical's average media sentiment score of 0.29 beat Avient's score of 0.26 indicating that Eastman Chemical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avient 8 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Eastman Chemical 15 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 10 Negative mention(s) 3 Very Negative mention(s) Neutral Which has better earnings and valuation, AVNT or EMN? Eastman Chemical has higher revenue and earnings than Avient. Eastman Chemical is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvient$3.24B0.94$169.50M$1.2825.87Eastman Chemical$9.38B0.75$905M$7.128.59 Which has more volatility and risk, AVNT or EMN? Avient has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Eastman Chemical has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. SummaryEastman Chemical beats Avient on 14 of the 20 factors compared between the two stocks. Get Eastman Chemical News Delivered to You Automatically Sign up to receive the latest news and ratings for EMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EMN vs. The Competition Export to ExcelMetricEastman ChemicalCHEM IndustryMaterials SectorNYSE ExchangeMarket Cap$7.00B$11.12B$3.27B$20.71BDividend Yield5.45%3.97%5.18%3.67%P/E Ratio8.5924.96106.0028.65Price / Sales0.755.5235,179,415,501,994,400.0069.00Price / Cash4.877.0523.9223.59Price / Book1.191.716.004.32Net Income$905M$507.50M$148.72M$995.66M7 Day Performance4.07%1.57%3.37%1.91%1 Month Performance-23.91%-6.44%4.20%-0.54%1 Year Performance-35.91%-1.06%36.68%14.76% Eastman Chemical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EMNEastman Chemical4.9512 of 5 stars$61.19+0.4%$87.00+42.2%-34.8%$7.00B$9.38B8.5914,000Dividend AnnouncementAnalyst ForecastAVNTAvient4.5944 of 5 stars$33.97+0.5%$45.60+34.2%-23.8%$3.11B$3.25B26.549,200Earnings ReportAnalyst RevisionCECelanese4.6424 of 5 stars$48.12-0.9%$66.50+38.2%-61.1%$5.26B$10.28B-3.1612,163Upcoming EarningsGap UpDDDuPont de Nemours4.4038 of 5 stars$70.86+1.3%$87.50+23.5%-8.2%$29.65B$12.52B-372.9324,000Positive NewsEarnings ReportAnalyst ForecastDOWDOW4.5838 of 5 stars$21.59-0.9%$29.94+38.7%-58.6%$15.30B$42.96B-15.4236,000Analyst UpgradeGap UpFULH. B. Fuller4.4822 of 5 stars$56.34+1.3%$67.25+19.4%-27.9%$3.04B$3.53B30.457,500HUNHuntsman4.477 of 5 stars$9.37+1.7%$12.72+35.8%-53.3%$1.63B$6.04B-4.816,300Trending NewsAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeLYBLyondellBasell Industries4.803 of 5 stars$50.89-4.7%$64.38+26.5%-47.1%$16.36B$38.66B66.1020,000Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastGap UpHigh Trading VolumeWLKWestlake4.0411 of 5 stars$76.27+1.1%$93.77+22.9%-42.8%$9.78B$12.14B25.5915,540Trending NewsEarnings ReportAnalyst UpgradeGap UpPPGPPG Industries4.6503 of 5 stars$104.94+0.5%$129.82+23.7%-10.3%$23.68B$15.64B23.8046,000Positive NewsFMCFMC4.4867 of 5 stars$37.72-0.8%$50.38+33.6%-40.5%$4.71B$4.13B47.155,700Trending NewsAnalyst Revision Related Companies and Tools Related Companies Avient Alternatives Celanese Alternatives DuPont de Nemours Alternatives DOW Alternatives H. B. Fuller Alternatives Huntsman Alternatives LyondellBasell Industries Alternatives Westlake Alternatives PPG Industries Alternatives FMC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EMN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eastman Chemical Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eastman Chemical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.